dedicated microvascular endothelial cell growth medium (Cell Applications Inc)
Cell Applications Inc is a verified supplier 
Cell Applications Inc manufactures this product 
96
Structured Review
Cell Applications Inc
dedicated microvascular endothelial cell growth medium
Dedicated Microvascular Endothelial Cell Growth Medium, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 393 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+microvascular+endothelial+cell+growth+medium/Major+Media/pm38981531-49-6-13
Average 96 stars, based on 393 article reviews
Dedicated Microvascular Endothelial Cell Growth Medium, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 393 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+microvascular+endothelial+cell+growth+medium/Major+Media/pm38981531-49-6-13
Average 96 stars, based on 393 article reviews
dedicated microvascular endothelial cell growth medium - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Cell Culture:Article Title: Distinct profile of antiviral drugs effects in aortic and pulmonary endothelial cells revealed by high-content microscopy and cell painting assays. Article Snippet: Antiviral drugs have significantly improved the treatment of viral infections and reduced the associated mortality and morbidity rates.. However, antiviral therapy may lead to an increased risk of cardiovascular diseases, which are related to endothelial toxicity.. Here, seven antiviral drugs (remdesivir, PF-00835231, ritonavir, lopinavir, efavirenz, zidovudine and abacavir) were characterized against aortic (HAEC) and pulmonary (hLMVEC) endothelial cells, using high-content microscopy. |